Rankings
▼
Calendar
GSK Q3 2025 Earnings — GSK plc Revenue & Financial Results | Market Cap Arena
GSK
GSK plc
$112B
Q3 2025 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$8.5B
Gross Profit
$6.3B
73.6% margin
Operating Income
$2.6B
30.3% margin
Net Income
$2.0B
23.6% margin
EPS (Diluted)
$0.98
Cash Flow
Operating Cash Flow
$3.0B
Free Cash Flow
$2.6B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$82.6B
Total Liabilities
$61.4B
Stockholders' Equity
$21.7B
Cash & Equivalents
$4.4B
All Quarters